NCT05866224

Brief Summary

The primary objective of this study is to evaluate the effects of a 15-week home telerehabilitation program and a detraining period on cardiorespiratory fitness and muscular efficiency in patients with post-COVID-19 sequelae compared to a control group of COVID-19 patients. We hypothesize that cardiorespiratory fitness and muscular efficiency significantly improve in patients who carry out the home telerehabilitation program. However, the cardiorespiratory and muscular adaptations achieved and tolerance to exercise are lost over time as an effect of detraining.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2023

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

May 16, 2023

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 19, 2023

Completed
Last Updated

May 19, 2023

Status Verified

May 1, 2023

Enrollment Period

2 years

First QC Date

May 16, 2023

Last Update Submit

May 16, 2023

Conditions

Outcome Measures

Primary Outcomes (6)

  • Cardiorespiratory fitness: absolute oxygen uptake

    absolute peak oxygen uptake in L/min

    1 week per group

  • Cardiorespiratory fitness: relative oxygen uptake

    relative peak oxygen uptake in L/min

    1 week per group

  • Exercise capacity during cardiopulmonary exercise test

    Exercise time in minutes and seconds

    1 week per group

  • Mechanical efficiency

    Delta efficiency in percentage

    1 week per group

  • Ventilatory efficiency

    VE/VCO2 slope

    1 week per group

  • Power output during pedaling

    Power output in watts

    1 week per group

Secondary Outcomes (9)

  • Respiratory exchange ratio

    1 week per group

  • Minute ventilation

    1 week per group

  • ventilatory equivalent for oxygen

    1 week per group

  • ventilatory equivalent for carbon dioxide

    1 week per group

  • End-tidal partial pressure of oxygen

    1 week per group

  • +4 more secondary outcomes

Study Arms (2)

Supervised home telerehabilitation program

EXPERIMENTAL

COVID-19 patients will perform a total of 15 weeks of a telerehabilitation program combined with aerobic and strength exercises using the circuit training methodology. COVID-19 patients will carry out 3 weekly sessions on non-consecutive days to avoid unnecessary overload and maximize the adaptations, completing a total of 45 sessions

Other: Telerehabilitation program

non-supervised control group

NO INTERVENTION

COVID-19 patients that will not perform the telerehabilitation program

Interventions

The supervised telerehabilitation program will be performed in the home of each patient and supervised by an experienced physiotherapist with more than 4 years of clinical experience in therapeutic exercise for chronic diseases.

Supervised home telerehabilitation program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age \> 18 years
  • molecular diagnosis (reverse transcription polymerase chain reaction \[RT-PCR\]) of infection by SARS-CoV-2
  • post-COVID-19 symptomatology

You may not qualify if:

  • severe neurological disease
  • active oncological disease
  • neuromuscular disease and/or orthopedic disorders impeding normal development of cardiopulmonary exercise test
  • the absence of signed informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Manuel Vicente Garnacho Castaño

Sant Boi de Llobregat, Barcelona, 08830, Spain

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Coordinator of the DAFNiS research group

Study Record Dates

First Submitted

May 16, 2023

First Posted

May 19, 2023

Study Start

January 1, 2021

Primary Completion

January 1, 2023

Study Completion

May 1, 2023

Last Updated

May 19, 2023

Record last verified: 2023-05

Locations